FDA Inspection 1106315 — UPMC Hematopoietic Stem Cell Laboratory
The FDA completed an inspection of UPMC Hematopoietic Stem Cell Laboratory on August 6, 2019 in Pittsburgh, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 6, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Pittsburgh, PA (United States)